You are here

Skysona

Bluebird touts Zynteglo, Skysona launch progress as FDA decision on sickle cell therapy nears

Fierce Pharma

Tue, 08/8/23 - 11:33 am

sickle cell disease

Gene therapy is saving lives, but key challenges to realize its full potential

MedCity News

Thu, 10/20/22 - 10:30 am

Bluebird wins FDA approval of gene therapy for rare brain disorder

BioPharma Dive

Sun, 09/18/22 - 10:23 pm

Bluebird, winding down in Europe, withdraws another rare disease gene therapy

BioPharma Dive

Thu, 10/21/21 - 11:17 pm

cerebral adrenoleukodystrophy

Bluebird, with little fanfare, is first to bring a second gene therapy to market

BioPharma Dive

Wed, 07/21/21 - 08:43 pm

cerebral adrenoleukodystrophy

Bluebird’s new gene therapy among three new EMA OKs ahead of FDA

Endpoints

Fri, 05/21/21 - 10:56 am

monoclonal antibodies